Federation Des Caisses Desjardins Du Quebec Atreca, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.06 - $0.36 $28 - $169	470 New	470 $38,000
Q3 2023 Aug 14, 2024	BUY	$0.26 - $1.12 $7 - $33	30 Added 6.82%	470 $123,000
Q1 2022 Aug 14, 2024	BUY	$1.61 - $5.2 $708 - $2,288	440 New	440 $1.4 Million
Q2 2021 Aug 30, 2024	BUY	$7.82 - $13.8 $3,440 - $6,072	440 New	440 $3.75 Million
Q1 2021 Aug 30, 2024	BUY	$13.0 - $19.34 $5,720 - $8,509	440 New	440 $6.75 Million

Others Institutions Holding BCEL

# of Institutions

Shares Held

30.6K

Call Options Held

Put Options Held

View Full List

About Atreca, Inc.

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

More about BCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account